Curefit will be tested
Mukesh Bansal’s Curefit has all the funding it needs, but little semblance of a strategy.
We rarely make our stories free to read. This one is, so make the most of it.
We publish over 500 original, detailed stories every year on startups, corporates, stock markets and economic current affairs.
No payment details required
$99 for one year
More in Internet
You may also like
SuperK has a playbook for solving India’s small-town retail problem
Investors are betting on the value retail chain’s franchise model to disrupt the retail market in small-town India. By the looks of it, the six-year-old startup seems to have gotten a lot of things right.
EaseMyTrip Q1 announcements show obfuscation, more pointless acquisitions
The online travel aggregator’s growth struggles get worse, even as it announces worryingly pointless acquisitions instead of setting its house in order. There’s no respite for its public shareholders.
Food delivery and loyalty: Lessons from Talabat
The Delivery Hero-owned company’s stellar quarterly earnings, a new move by Saudi markets and other important stories of the week.